alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice - Wikidata - thesis-toulmin - TriplyDB

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

http://www.wikidata.org/entity/Q36935759

about

The mitochondrial Na+/Ca2+ exchanger upregulates glucose dependent Ca2+ signalling linked to insulin secretion α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8 Human T regulatory cell therapy: take a billion or so and call me in the morning Survival of encapsulated islets: More than a membrane story T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-Antitrypsin Immune-directed therapy for type 1 diabetes at the clinical level: the Immune Tolerance Network (ITN) experience Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes Expanding the clinical indications for α(1)-antitrypsin therapy Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin BALB/c mice show impaired hepatic tolerogenic response following AAV gene transfer to the liver.α1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1β responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes.Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation Investigating and Annotating the Role of Citation in Biomedical Full-Text Articles α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics.Creating transplant tolerance by taming adverse intragraft innate immunity.Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.The immunoregulation effect of alpha 1-antitrypsin prolong β-cell survival after transplantation Innate immune activation by tissue injury and cell death in the setting of hematopoietic stem cell transplantation.α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.Alpha-1-antitrypsin monotherapy reduces graft-versus-host disease after experimental allogeneic bone marrow transplantation.Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus.Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival.Human Alpha-1-Antitrypsin (hAAT) therapy reduces renal dysfunction and acute tubular necrosis in a murine model of bilateral kidney ischemia-reperfusion injury.Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of α-1 antitrypsin treatment Effect of recombinant α1-antitrypsin Fc-fused (AAT-Fc)protein on the inhibition of inflammatory cytokine production and streptozotocin-induced diabetes.Curative and beta cell regenerative effects of alpha1-antitrypsin treatment in autoimmune diabetic NOD mice.Anti-inflammatory Agents: Present and Future The complement factor 5a receptor 1 has a pathogenic role in chronic inflammation and renal fibrosis in a murine model of chronic pyelonephritis Alpha-1 antitrypsin reduces severity of pseudomonas pneumonia in mice and inhibits epithelial barrier disruption and pseudomonas invasion of respiratory epithelial cells Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs Regulatory B cells and tolerance in transplantation: from animal models to human.Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.The role of complement in the early immune response to transplantation.Immune-modulating effects of alpha-1 antitrypsin.The multiple facets of alpha-1-antitrypsin.Immune protective effect of human alpha-1-antitrypsin gene during β cell transplantation in diabetic mice.

P2860

Q24300697-72FF071D-860B-422C-9721-BAD0195B4EBD Q24633462-CF95B56B-45B7-4B86-A353-D42010EEDC6E Q24656069-02AEC7A5-C6D3-469A-A274-E7887A53D025 Q26751467-3ABDA947-B898-4712-A3FE-5AA3510189BA Q26829272-3AE2E68F-8374-4591-9873-265C65771703 Q26850621-4E514B97-ABEE-4E90-B75B-4206EAA69CB7 Q26858837-A296373D-417F-4B23-89D5-321D1A11BD87 Q26861561-1D9CC4DA-815C-490E-9D16-5936BA9E5964 Q27000764-1B29653B-70D1-47A6-8577-D03832E7EEBD Q28395194-AEE2E01B-A5D2-4536-A1B7-E0FB3C45BCDA Q28817846-FC3DA1C9-95C5-4C8F-B517-7286C052C891 Q33822204-6D205F6D-F0B2-4B0C-A62C-BC15BBE75F58 Q33999020-CA282B00-0DA8-42E3-B796-6B194C194E96 Q34056108-5205583A-AB73-4B7F-9064-B36AF7424D27 Q34412466-095CF034-60C0-4F94-8BCD-B715DDC25AAC Q34431458-F63FA76F-ED12-43D1-91D7-778A65588C18 Q34519401-877A567D-6B58-4363-9256-7BD72A6D2F32 Q34744307-A0E1D8A1-D579-420E-BFB2-FB890574CA0E Q35145461-F6A25C75-A89D-4DCE-A9BE-88BABC71D89A Q35179622-A21AA58A-2526-49D0-97B0-3B7A1B3C2573 Q35286904-0DBCBA4A-CAEA-462F-B0EC-0FB646FAD51B Q35525740-10484AA1-3D9D-4DCD-9B6D-55191E6C0A73 Q35673668-666DA29B-D38A-47C4-A122-31864845B966 Q36032325-F0194346-6FAD-4569-91C1-C1D5612AEC74 Q36280053-264983B6-6178-488F-BC96-1C9EFA1AD64E Q36290085-A88D77D0-92DD-4ACC-87CD-5304281B5CB2 Q36305350-098D682E-C02F-4ABD-A69E-DFB7F571E4E5 Q36655234-F01BDDBC-79FB-4DF1-ADFF-7C7A5D4DAFAB Q36885672-D014CB1A-CA3B-4B63-BF39-D23E146232F0 Q36945031-1626EFE6-D112-4C4D-BF74-02871CE2CD1B Q37118156-75F8A616-7BBE-4AEE-A1E5-86C003B31137 Q37201208-E0ED92F6-BFA9-4DE0-886A-C19B450F2FC8 Q37372512-FF901DFE-FB84-4F95-8A4B-D3C7F11442DA Q37400370-5D93104A-508C-4766-AF9D-96EE3887AD25 Q37420774-B5578C63-B072-45F0-9847-57D6F2248604 Q37427900-3A04EA18-531C-4207-8A81-AE67A112EC3F Q38013049-22F8A233-743F-48EA-A27B-7249C2B70B62 Q38214040-5A5B6D0F-2058-44C3-AA37-AB60AA2BDC96 Q38553419-E1E6A163-A7C6-4AF4-A3AA-FEE738FEE3DC Q38899884-F62DDD5F-AE59-4C4C-B5DC-3311B022CD65

P2860

alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice

http://www.wikidata.org/entity/Q36935759

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

alpha1-Antitrypsin monotherapy ...... ograft transplantation in mice

@en

type

label

alpha1-Antitrypsin monotherapy ...... ograft transplantation in mice

@en

prefLabel

alpha1-Antitrypsin monotherapy ...... ograft transplantation in mice

@en

P1433

Q36935759-0184461C-365D-4428-A4C1-28869ADAB34D

P1476

Q36935759-6D078688-3001-46E3-A254-03C91F9C31E6

P2093

Q36935759-0973C204-DB6A-4843-B875-AE55D41D70EA

Q36935759-4DEA198F-8B97-4529-A4EF-AE7C6D1BB9F8

Q36935759-61168BFF-1776-429C-B062-3F19FC8F36A1

Q36935759-A8DAA9C8-56B0-4254-98EE-22BE626D70DC

Q36935759-B802F8B9-FFF4-4A07-91FC-C4AF387AFFB5

Q36935759-EEF9416B-851D-4BC8-A085-5DC162000CF4

Q36935759-EFDB8F06-C5B0-41C0-BC19-ADF29E0085C1

P2860

Q36935759-00967A9A-7BEE-4A61-B699-E8FB9FD0802F

Q36935759-092CEA60-6196-4106-B74A-5D0894A360CD

Q36935759-0ADF5CB2-D1EE-473B-838F-6423A73BFEB1

Q36935759-0C5AB3A4-27B0-4B7B-B2DE-637FDA00A3A0

Q36935759-0D978DD8-84F5-46B5-8A83-8ED2FFEB03CD

Q36935759-21048504-658C-41F6-B496-CA5B9E7DF1E0

Q36935759-232059BE-B9E0-4230-ACD0-6AAB52C11317

Q36935759-30DCCA02-ECB1-427C-822C-840A63340200

Q36935759-3636F8E9-E98B-4CCF-B954-0208FD4B663D

Q36935759-41954457-3DBD-4C3E-8523-C4D7C45F4958

P304

Q36935759-C04318AF-AFB5-4CB6-9C29-7BB2B32A6AFB

P31

Q36935759-76DD7229-8013-4B95-9D1E-247A3ABE924C

P356

Q36935759-7AED6E8D-83B0-445D-ADB8-F5FF1B302323

P407

Q36935759-F4CF7570-DFB4-40CD-94CA-19F1BC8E2E57

P433

Q36935759-B2A5F562-E8AC-475F-B65E-DAD831678C42

P478

Q36935759-DD3CF433-9577-445E-9965-3E284ABE0AAE

P50

Q36935759-466F433E-8168-4589-80DA-B0A3F3304AF8

P577

Q36935759-A0157860-6175-4E2B-A227-DE2F025AF7A2

P5875

Q36935759-FB3AB534-8AEA-44D1-8741-1E9F0D672785

P698

Q36935759-6F5CDB4B-7A46-42C9-9AE8-90E13A295E1B

P932

Q36935759-68027DCE-3F48-4365-8ED3-5171A4197F11

P356

PNAS.0807627105

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

alpha1-Antitrypsin monotherapy ...... ograft transplantation in mice

@en

P2093

Andrew Churg

http://www.w3.org/2001/XMLSchema#string

Eli C Lewis

http://www.w3.org/2001/XMLSchema#string

Joanne L Wright

http://www.w3.org/2001/XMLSchema#string

Leland Shapiro

http://www.w3.org/2001/XMLSchema#string

Mark Mizrahi

http://www.w3.org/2001/XMLSchema#string

Michel Toledano

http://www.w3.org/2001/XMLSchema#string

Nathaniel Defelice

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation

Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism

How dying cells alert the immune system to danger

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

Augmentation therapy reduces frequency of lung infections in antitrypsin deficiency: a new hypothesis with supporting data.

Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

Differentiation of T regulatory cells by immature dendritic cells.

Tolerance and autoimmunity.

P304

16236-16241

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0807627105

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Charles A. Dinarello

P577

2008-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23314649

http://www.w3.org/2001/XMLSchema#string

P698

18852465

http://www.w3.org/2001/XMLSchema#string

P932

2566995

http://www.w3.org/2001/XMLSchema#string